medroxyPROGESTERone Acetate Injectable Suspension recall: Sterility Concern
medroxyPROGESTERone Acetate Injectable Suspension, USP, 1 mL Prefilled Syringe, 150 mg/mL, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN…
Why was medroxyPROGESTERone Acetate Injectable Suspension recalled?
Lack of assurance of sterility
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot#: HAC1289A, Exo 06/2023; JKX2679A, Exp 06/2022; JKX3762A, Exp 08/2022; HAC0164A, Exp 06/2023.
- Product
- medroxyPROGESTERone Acetate Injectable Suspension, USP, 1 mL Prefilled Syringe, 150 mg/mL, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN…
- Recalling firm
- SUN PHARMACEUTICAL INDUSTRIES INC
- Quantity
- 57997 syringes
- Distribution
- USA Nationwide
- Recall date
- June 22, 2022
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)